I. - Basic information

I.1 - Surname

Tumova

I.2 - Name

Ingrid

I.3 - Degrees

doc., RNDr., CSc.

I.4 - Year of birth

1952

I.5 - Name of the workplace

Faculty of Pharmacy Comenius University

I.6 - Address of the workplace

Odbojárov 10, 832 32 Bratislava

I.7 - Position

professor

I.8 - E-mail address

tumova@fpharm.uniba.sk

I.10 - Name of the study field in which a person works at the university

Pharmacy

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy Comenius University

II.b - Year

1970-1975

II.c - Study field and programme

Pharmacy

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy Comenius University

II.b - Year

1970 -1975

II.c - Study field and programme

Pharmacy

II.3 - Third degree of higher education

II.a - Name of the university or institution

Faculty of Pharmacy Comenius University

II.b - Year

1988

II.c - Study field and programme

Pharmacology

II.4 - Associate professor

II.a - Name of the university or institution

Faculty of Pharmacy Comenius University

II.b - Year

1994

II.c - Study field and programme

Pharmacology

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
university teacher	Faculty of Pharmacy Comenius University	1975 - 2022
university teacher

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
University teacher, guarant of subjects -Pharmacology and toxicology, Toxicology xenobiotics, First aid	Faculty of Pharmacy Comenius University	1975 - 2022

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pharmacology and Toxicology	Pharmacy	combined I. and II. degree	Pharmacology
Toxicology xenobiotics	Pharmacy	combined I. and II. degree
Clinical pharmacology and Pharmacotherapy	Pharmacy	combined I. and II. degree
First aid	Pharmacy	combined I. and II. degree, I. degree

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.3.a - Name of the field of habilitation procedure and inaugural procedure	V.3.b - Study field to which it is assigned
Pharmacology	Pharmacology

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.2 - Number of defended theses

V.4.a - Bachelor's (first degree)

V.4.b - Diploma (second degree)

more than 200

V.4.c - Dissertation (third degree)

6 dissertations

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree
Pharmacology and toxicology	Pharmacy	combined I. and II. degree
Clincal Pharmacology and Pharmacotherapy	Pharmacy	combined I. and II. degree
First aid	Pharmacy	combinet I. and II. degree Pharmacy, I. degree - Medical devices

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

257

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.5 - Number of invited lectures at the international, national level

VI.1.a - Overall

more than 15

VI.2 - The most significant research/artistic/other outputs

Marei, H. - Tumová, Ingrid [UKOFAFT] - Lemmens-Gruber, R. - Heistracher, P.: Electrophysiological Effects of GE 70 in Isolated Papillary Muscle and Ventricular Myocytes of Guinea Pig Hearts

In: Experimental and Clinical Cardiology. - Vol. 2, No. 1 (1997), p. 65-68.

Švec, Pavel - Račanská, Eva [UKOFAFTs] - Tumová, Ingrid [UKOFAFT] - Inczinger, František: Príspevok k analýze mechanizmu vzniku "Rebound" fenoménu po betalytikách

In: Bratislava medical journal. - Roč. 71, č. 4 (1979), s. 377-504.

Čižmárik, Jozef [UKOFAFCH] - Borovanský, Alois - Tumová, Ingrid [UKOFAFT]: Untersuchungen an Lokalänesthetica Teil 91 : Morpholinoethylester der Alkoxyphenylcarbamidsäuren

In: Pharmazie. - Vol. 42, No. 10 (1987), p. 702-703.

Tumová, Ingrid [UKOFAFT] - Švec, Pavel: Pharmacological properties of a new local-anesthetic, carbiscocaine

In: Drugs under Experimental and Clinical Research. - Vol. 12, No. 9-10 (1986), p. 845-851. - ISSN 0378-6501

Blahová, Mária - Tumová, Ingrid [UKOFAFT] - Sokolík, Jozef - Gallasová, M. - Švec, Pavel: Anti-inflammatory activity of aqua(aryloxyacetato)copper(II) complexes.

In: Pharmazie. - Vol. 49, No. 5 (1994), s. 373-374.

Albrecht, G. - Ecker, G. - Tumová, Ingrid [UKOFAFT]: Herstellung und antiphlogistische Aktivität neuer 1-Benzoxepin-5-on-Derivate

In: Scientia Pharmaceutica. - Vol. 61 (1993), p. 161-168.

Trtílek, Vladimír, Abrmanová, Hana, Uhríková, Zuzana, Maťašová, Katarína, Tumová, Ingrid,-Zibolen, : Neskoré komplikácie syndrómu dychovej tiesne upredčasne narodených novorodencov

In: Pediatria. - Roč. 5, č. 4 (2010), s. 194-197.

Rubintová, Dominika, Pinček, Martin, Lacka, Jozef, Foltánová, Tatiana,Tumová, Ingrid, - Kosírová, Stanislava: Hodnotenie rizika score u pacientov poantidiabetickej liečbe

In: Farmaceutický obzor. - Roč. 87, č. 8 (2018), s. 217-218

VI.3 - The most significant research/artistic/other outputs over the last six years

Mišúth, Svetozár, Tumová, Ingrid , Klimas, Ján ,Vavrincová-Yaghi, Diana,Vavrinec,: Vildagliptín znižuje predčasnú stresom indikovanú senescenciu vaskulárnehohladkého svalu aorty potkana prostredníctvom pôsobenia glukagónu podobnému peptidu 1 = Vildagliptin reduces stress-induced premature senescence of rat aortic vascular smooth muscle through action of glucagon-like pepetide 1

In: Pokroky vo farmakológii v Slovenskej republike 12. - Bratislava : Farmaceutická fakulta UK, 2017. - S. 14-20. - ISBN 978-80-223-4419-7

Poništ, Silvester, Dráfi, František, Kuncírová, Viera, Mihalová, Danica, - Račková, Lucia, Danišovič, Ľuboš Ondrejičková, Oľga, Tumová, Ingrid, Trunová, Oľga, Fedorova,Tatiana, Bauerová, Katarína : Effect of carnosine in experimental arthritis and on primary culture chondrocytes

In: Oxidative Medicine and Cellular Longevity [elektronický zdroj]. - Vol. 2016 (2016), Art. No. 8470589 [11 s.] [online]. - ISSN 1942-0994

Rubintová, Dominika, Pinček, Martin, Foltánová, Tatiana,Tumová, Ingrid, Kosírová, Stanislava: Hodnotenia zmien HbA1C a score počas liečby diabetických pacientov = Evaluation of HbA1C and score in treatment of diabetic patients

In: Pokroky vo farmakológii v Slovenskej republike 14. - Bratislava : Farmaceutická fakulta UK, 2019. - S. 69-75. - ISBN 978-80-223-4813-3

Tumová, Ingrid, Švec, Pavel, Duriš Adameová, Adriana, Račanská, Eva: Toxikológia pre farmaceutov : učebnica pre vysoké školy. - 1. vyd. - Bratislava : Herba, 2016. - 192 s., ISBN 978-80-89631-56-8

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Raffin, R.P. - Colomé, L.M. - Haas, S.E. - Jornada, D.S. - Pohlmann, A.R. - Guterres, S.S.: Pharmazie, Vol. 62, No. 5, 2007, s. 364 - SCOPUS

Gumilar, F. - Agotegaray, M. - Bras, C. - Gandini, N. - Minetti, A. - Quinzani, O.: European Journal of Pharmacology, Vol. 675, No. 1-3, 2012, s. 39 - SCOPUS

József Szentmiklósi, A. - Szentandrássy, N. - Hegyi, B. - Horváth, B. - Magyar, J. - Bányász, T. - Nánási, P.P.: Current Pharmaceutical Design, Vol. 21, No. 8, 2015, s. 1041 - SCOPUS

Schaalan, M.F. - Ramadan, B.K. - Abd Elwahab, A.H.: Journal of Cellular Physiology, vol. 233, no. 6, 2018, s. 5044-5057 - SCI ; SCOPUS

Zhang, Z.D. - Yang, Y.J. - Liu, X.W. - Qin, Z. - Li, S.H. - Bai, L.X. - Li, J.Y.: Oxidative Medicine and Cellular Longevity, 2021, art. no. 5527475 - SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

Project number: APVV-15-0308

Project title: Molecular-pharmacological approaches to innovative rheumatoid therapy

arthritis evaluated in experimental conditions

Responsible researcher for SAS: PharmDr. Katarina Bauerova, CSc.

Investigator for the Ministry of Education of the Slovak Republic: doc. RNDr. Ingrid Tumova, CSc.

Project solution period: 2016-2020

Brief annotation of results:

The focus of the project is the study of the therapeutic potential of selected substances for therapy rheumatoid arthritis (RA), especially for combination therapy with methotrexate.

Project type: VEGA

Project number: 2/0044/2015

Project title: Research into the influence of inflammation, chronic autoimmune response and redox regulation of the organism in experimental arthritis using new substances for adjuvant therapy of rheumatoid arthritis.

Responsible researcher for SAS: PharmDr. Katarina Bauerova, DrSc.

Co-researcher: doc. RNDr. Ingrid Tumova, CSc.

Brief annotation of results:

The project aims to reveal the unknown mechanisms of etiopathogenesis of RA, up to the level of expression of important Ntf2 and NF-kappa B genes involved in the regulation of inflammation and redox balance of the organism. For this purpose, we will use an experimental model of RA, namely adjuvant arthritis (AA) induced in Lewis rats. The AA breakdown will be characterized by parameters describing immunological, oxidative and inflammatory processes. In this model, in combination with an acute model (carrageenan-induced inflammation) and cell culture (BV-2 mouse microglia stimulated with inflammation), we evaluate the antirheumatic effect of substances that have not been studied in a rat model of adjuvant arthritis (antioxidants: astaxanthin, troloxolol, carnozole). selected phytochemicals and extracts.The most effective of the studied substances will then be combined with methotrexate.The expected benefit is to increase the effectiveness of methotrexate without increasing the risk of side effects.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position	VII.b - Name of the institution, board	VII.c - Duration
vice dean for educational activities	Faculty of Pharmacy Comenius University	2003 - 2010
Head of the Department of Pharmacology and Toxicology	Faculty of Pharmacy	2010 - 2014

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution	VIII.b - Address of the institution	VIII.c - Duration (indicate the duration of stay)	VIII.d - Mobility scheme, employment contract, other (describe)
Institut fur Pharmakodynamik und Toxikologie der Universitat Wien, Austria	Wien, Austria	1991 - 1992

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Awards - Silver medal, Commemorative medal, Galen´s medal Faculty of Pharmacy Comenius University, medal PhMr. Vladimíra Žuffu, medal of the Slovak Pharmaceutical Society

Name and surname:	doc. RNDr. Ingrid Tumová, CSc.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava